Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Record is Archived

    This article is now archived and is closed to further replies.

    Jefferson Adams
    Jefferson Adams

    Company Options Promising New Celiac Disease Treatment

    Reviewed and edited by a celiac disease expert.

    Celiac.com 04/01/2011 - Cephalon has signed an agreement that gives the company the option to purchase a potentially promising new treatment for celiac disease from Alba Therapeutics.

    The deal calls for Cephalon to pay Alba a $7 million upfront fee, and to offering funding support for a phase IIb trial of the drug in question, a tight junction modulator known as larazotide acetate.

    Celiac.com Sponsor (A12):
    The deal allows Cephalon to acquire all assets relating to the treatment for an additional payment of $15 million, within specified time window, once trial data have been published

    Cephalon CEO, Kevin Buchi, said the company's interest is based on encouraging trial data for the drug thus far.

    If larazotide acetate proves to be effective against celiac disease, it "has the potential to be the first pharmacologic therapy available to treat patients who endure this often serious condition," Buchi said.

    Source:

    • Open Original Shared Link

     


    User Feedback

    Recommended Comments

    Guest mmayank soni

    Posted

    I am waiting for this good result of medicine as my 10 year son is suffering from celiac.

    Link to comment
    Share on other sites


    Guest
    This is now closed for further comments

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Jefferson Adams

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University. His articles, essays, poems, stories and book reviews have appeared in numerous magazines, journals, and websites, including North American Project, Antioch Review, Caliban, Mississippi Review, Slate, and more. He is the author of more than 2,500 articles on celiac disease. His university coursework includes studies in science, scientific methodology, biology, anatomy, physiology, medicine, logic, and advanced research. He previously devised health and medical content for Colgate, Dove, Pfizer, Sharecare, Walgreens, and more. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of numerous books, including "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

    >VIEW ALL ARTICLES BY JEFFERSON ADAMS

     


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Scott Adams
    The following contributions can be made to the United Way to support celiac sprue research:
    Celiac Sprue Flourtown, PA; Agency Code 030289 Celiac Sprue Association of United Omaha, NE; Agency Code 026760


    Scott Adams
    A little boy with a severe seizure disorder had his wish to have a special bike of his own granted through national children’s charity Kids Wish Network.
    Champaign, IL, August 14, 2010 --(PR.com)-- As a child, Joshua was diagnosed with having Intractable Epilepsy, a disorder in which he experiences seizures that are completely uncontrollable; he currently endures around four major seizures a day. Over the years, Joshua’s doctors have tried well over 10 different seizure medications to try and regulate his condition, but none have worked, including the 3 he is currently taking.
    Because of the severity of his condition, Joshua also suffers from developmental delays that have impaired his motor skills to the point where he cannot do much of anything without assistance; his communication ski...


    Jefferson Adams
    Celiac.com 01/20/2011 - Over his five years as a participant in Project Bread’s annual Walk for Hunger, 16-year-old high school sophomore, Pierce Keegan came to realize that more needed to be done to supply gluten-free food to people in need.
    “When I was doing the Walk for Hunger, I suddenly thought, ‘What if I needed food? Would I be able to get gluten-free products if I couldn’t afford them?’’’
    Inspired by his success in raising nearly $5,000 for Project Bread, Keegan founded Pierce’s Pantry to supply gluten-free food to people who need food, and need that food to be gluten-free.
    Pierce's Pantry officially launched on January 1st, 2011, and  collects and distributes gluten-free products to local food pantries. Keegan has so far received donations from 12 food manufacturers, a...


    Dr. Ron Hoggan, Ed.D.
    More Resistance to the Large Prevalence of Celiac Disease
    This article originally appeared in the Spring 2011 edition of Celiac.com's Open Original Shared Link.
    Celiac.com 09/07/2011 - Through the hard work and concerted efforts of many support groups and individuals throughout the US, along with the generosity of Instituto Di Ricerca in Italy, research funding was accumulated. Early in the Twenty-First Century, under the auspices of the Center for Celiac Disease Research, a new epoch in celiac disease awareness was born. Spearheaded by Dr. Alessio Fasano and several other prominent gastroenterologists, a large multi-center study was undertaken and the rate of celiac disease in the general U.S. population was determined to be at least 1 in 133 (1). This pains-taking, thorough, time-consuming and expensive research started a landslide of opinions...


    Jefferson Adams
    Celiac.com 10/29/2013 - In an effort to get a better understanding of the prevalence of celiac disease in Germany, a team of researchers recently conducted a randomly selected population sample.
    The research team included W. Kratzer, M. Kibele, A. Akinli, M. Porzner, B.O. Boehm, W. Koenig, S. Oeztuerk, R.A. Mason, R. Mao, and M.H. Haenle. They are affiliated with the Department of Internal Medicine I at the University Hospital Ulm in Ulm, Germany.
    For their population-based cross-sectional study, the team conducted laboratory testing for tissue transglutaminase and antibodies to immunoglobulin A, endomysium and antigliadin in a total of 2157 subjects (1036 males; 1121 females).
    Next, the team used a questionnaire, that included celiac-specific questions, to survey all subjects...


    Jefferson Adams
    Celiac.com 04/18/2015 - Research is underway on a number of new drugs intended to celiac disease treatment beyond a simple gluten-free diet. However, even though several drugs are in Phase 2 trials and results appear promising, discussion around regulatory endpoints is just beginning.
    A research team recently reviewed endpoints for Phase 2 and 3 trials of new celiac disease drugs currently under development, and detailed their results in a scientific paper. The team included Klaus Gottlieb, Jill Dawson, Fez Hussain and Joseph A. Murray. They are variously affiliated with the department of Immunology and Internal Medicine of Medical Strategy & Science, Quintiles, Durham, NC, USA, with Corporate Communications, Quintiles, Durham, NC, USA, and with the Division of Gastroenterology and...


  • Recent Activity

    1. - jjiillee replied to jjiillee's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      10

      Daughter waiting for appointment

    2. - cristiana replied to cristiana's topic in Gluten-Free Recipes & Cooking Tips
      2

      Christmas Cake

    3. - Scott Adams replied to Mmar's topic in Post Diagnosis, Recovery & Treatment of Celiac Disease
      1

      Refractory Celiac - doctor?

    4. - Scott Adams replied to aperlo34's topic in Related Issues & Disorders
      1

      Eye irritation 2.5 months into gluten free diet


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      126,510
    • Most Online (within 30 mins)
      7,748

    Dave Dankenbrink
    Newest Member
    Dave Dankenbrink
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.9k
    • Total Posts
      69.5k

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • Art Maltman
      4
    • JA917
      13
    • Dana Gilcrease
      5
    • marion wheaton
      6
    • Jula
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...